Vanderbilt-ingram Cancer Center
Clinical trials sponsored by Vanderbilt-ingram Cancer Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can freezing kill lung cancer? new study tests cryodevitalization Results expected Dec 2026 (estimated)
- AI could help avoid unnecessary lung procedures Results expected Jan 2027 (estimated)
- 4,000 volunteers help scientists hunt lung cancer clues in body fluids Results expected Jan 2027 (estimated)
- New drug combo aims to outsmart resistant leukemia Results expected Feb 2027 (estimated)
- Scientists create massive breast tissue library to unlock cancer secrets Results expected Mar 2027 (estimated)
-
Can freezing kill lung cancer? new study tests cryodevitalization
Disease control OngoingThis study tests a procedure called cryodevitalization, which uses a flexible probe to freeze and kill early-stage lung cancer cells. It is done during a standard biopsy. The goal is to find the safest freezing time and see if the treatment is tolerable for 30 patients with stage…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New biomarker model aims to reduce unnecessary lung biopsies
Diagnosis OngoingThis study is testing a combined biomarker model (CBM) that uses a blood test and CT scan features to better classify lung nodules as benign or cancerous. Researchers will follow 103 adults with intermediate-risk nodules to see if the model can reduce unnecessary invasive procedu…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
AI could help avoid unnecessary lung procedures
Diagnosis OngoingThis study tests whether an artificial intelligence (AI) tool called the Virtual Nodule Clinic can help doctors better manage lung nodules that are not clearly cancerous or benign. The AI analyzes CT scans and patient information to estimate the risk of cancer. The goal is to see…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Can a Lower-Dose radiation 'Rotisserie' treatment ease skin lymphoma symptoms?
Symptom relief PausedThis trial is testing whether low-dose total skin electron therapy, given while a person stands on a rotating platform, can improve quality of life for people with mycosis fungoides that has returned or not responded to prior treatment. Participants receive standard radiation car…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
New study aims to catch lung cancer early in those who Can't afford care
Knowledge-focused OngoingThis study follows 45 uninsured current or former heavy smokers to find early signs of lung cancer. Researchers collect samples like sputum, blood, and urine, and perform CT scans to test new detection methods. The goal is to improve early diagnosis in a group that often misses o…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New study tests tools to help families share cancer genetic results
Knowledge-focused OngoingThe IMPACT Study is testing two online tools—GeneSHARE and LivingLabReport—to help people with inherited cancer gene variants share their results with family members and follow cancer screening guidelines. The study involves 720 adults who have a genetic variant linked to cancers…
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:58 UTC